❌

Normal view

Received today — 7 October 2026 ⏭ Journals

Oncogene - Issue - nature.com science feeds
ACTB promotes ESCC progression by regulating the AKT–mTOR signaling pathway through an m<sup>6</sup>A-dependent mechanism Yunshan Jiang · Dan Zhao · Dongxia Liao · Fengling Yang · Canyang Lin · Pengfei Liu · Zheyuan Chen · Fang Shaobo · Xiaoxue Deng · Xiaolei Ni · Baoling Guo
Oncogene, Published online: 30 September 2026; doi:10.1038/s41388-026-03995-3ACTB promotes ESCC progression by regulating the AKT–mTOR signaling pathway through an m6A-dependent mechanism
30 September 2026 at 08:00

ACTB promotes ESCC progression by regulating the AKT–mTOR signaling pathway through an m<sup>6</sup>A-dependent mechanism

Oncogene - Issue - nature.com science feeds

By: Yunshan Jiang · Dan Zhao · Dongxia Liao · Fengling Yang · Canyang Lin · Pengfei Liu · Zheyuan Chen · Fang Shaobo · Xiaoxue Deng · Xiaolei Ni · Baoling Guo

30 September 2026 at 08:00

Oncogene, Published online: 30 September 2026; doi:10.1038/s41388-026-03995-3

ACTB promotes ESCC progression by regulating the AKT–mTOR signaling pathway through an m⁶A-dependent mechanism

Received — 15 September 2026 ⏭ Journals

Oncogenesis - nature.com science feeds
Acrolein- thioredoxin 1- p38 signaling drives neutrophil-mediated immunosuppression and glioblastoma progression Zhen-Jie Tong · Tsong-Long Hwang · Kuo-Chen Wei · Chiung-Yin Huang · Pin-Yuan Chen · Ko-Ting Chen · Ya-Jui Lin · Hong-Chieh Tsai · Hsiang-Tsui Wang
Oncogenesis, Published online: 14 September 2026; doi:10.1038/s41389-026-00655-9Acrolein- thioredoxin 1- p38 signaling drives neutrophil-mediated immunosuppression and glioblastoma progression
14 September 2026 at 08:00

Acrolein- thioredoxin 1- p38 signaling drives neutrophil-mediated immunosuppression and glioblastoma progression

Oncogenesis - nature.com science feeds

By: Zhen-Jie Tong · Tsong-Long Hwang · Kuo-Chen Wei · Chiung-Yin Huang · Pin-Yuan Chen · Ko-Ting Chen · Ya-Jui Lin · Hong-Chieh Tsai · Hsiang-Tsui Wang

14 September 2026 at 08:00

Oncogenesis, Published online: 14 September 2026; doi:10.1038/s41389-026-00655-9

Acrolein- thioredoxin 1- p38 signaling drives neutrophil-mediated immunosuppression and glioblastoma progression

Received — 10 September 2026 ⏭ Journals

Cell
Targeting peripheral 5-HT2AR enhances antitumor immunity in colorectal cancer YaTing Wen · LingJie Tang · WenWen Duan · QingFei Ren · YangYue Ni · ShiYang Chen · Jun Chen · Lei Yang · Huan Wang · Yuan Chen · YunZhe Zheng · XingChao Pan · Hui Du · MengWen Huang · An Zeng · Zhaocai Zhou · ZhiGang Zhang · HongBin Ji · GaoXiang Ge · Yi Arial Zeng · Wei Zhang · ShiHui Wang · JianJun Cheng · Sheng Wang · JianFeng Chen
By selectively targeting peripheral 5-HT2AR without inducing psychedelic effects, a non-brain-penetrant agonist boosts antitumor CD8+ T cell immunity and improves immunotherapy responses in preclinical models of colorectal cancer.
4 August 2026 at 08:00

Targeting peripheral 5-HT2AR enhances antitumor immunity in colorectal cancer

Cell

By: YaTing Wen · LingJie Tang · WenWen Duan · QingFei Ren · YangYue Ni · ShiYang Chen · Jun Chen · Lei Yang · Huan Wang · Yuan Chen · YunZhe Zheng · XingChao Pan · Hui Du · MengWen Huang · An Zeng · Zhaocai Zhou · ZhiGang Zhang · HongBin Ji · GaoXiang Ge · Yi Arial Zeng · Wei Zhang · ShiHui Wang · JianJun Cheng · Sheng Wang · JianFeng Chen

4 August 2026 at 08:00

By selectively targeting peripheral 5-HT2AR without inducing psychedelic effects, a non-brain-penetrant agonist boosts antitumor CD8+ T cell immunity and improves immunotherapy responses in preclinical models of colorectal cancer.